{"id":105361,"date":"2026-10-27T15:51:43","date_gmt":"2026-10-27T14:51:43","guid":{"rendered":"https:\/\/translinguoglobal.com\/pharmaceutical-translation-for-businesses-guidelines-and-security\/"},"modified":"2026-10-27T15:51:43","modified_gmt":"2026-10-27T14:51:43","slug":"pharmaceutical-translation-for-businesses-guidelines-and-security","status":"publish","type":"post","link":"https:\/\/translinguoglobal.com\/en\/pharmaceutical-translation-for-businesses-guidelines-and-security\/","title":{"rendered":"Pharmaceutical Translation for Businesses: Guidelines and Security"},"content":{"rendered":"

Pharmaceutical translation<\/strong> is a specialised type of translation of documentation regulated by medical authorities – this includes information leaflets, technical data sheets, clinical testing protocols, and pharmacovigilance reports, where a mistake in terminology isn’t just a sign of poor quality, but a regulatory risk and at worst a risk to the patient’s medical. In contrast with other types of translation, here it’s not enough to merely ‘understand the text’, you also need traceability, standardised terminiology, and a revision process which can be presented to a medical authority if necessary.<\/p>\n

In this article, we will explain what distinguishes pharmaceutical translation<\/strong> from medical translation<\/strong>, what type of information leaflet translation<\/strong> or clinical trial translation<\/strong> requires more proofreading, and howISO certificates 17100<\/strong> and 13485<\/strong> support the process.<\/p>\n

At Translinguo Global, a professional translation company<\/strong>, we have translators who are specialised in scientific and pharmaceutical translation. We have more than 10 years of experience in the sector, having worked with important companies from the sector.<\/p>\n

What is pharmaceutical translation and why is it especially demanding?
\n
This specialisation comes under the category of scientific translation, but with an extra layer which differentiates it from other types of technical content: almost everything that is translated must then be reviewed by a standardising authority, whether that be the AEMPS in Spain, the EMA throughout Europe, or the FDA in the United States. This external supervision completely changes the level of demand throughout the translation process.<\/h2>\n

It isn’t just about ‘correctly’ translating the general sense of the text, but about producing a text which is traceable, with terminology that remains consistent across the drafts, and in line with the format expected throughout the market. An information leaflet, a technical data sheet, or an informed consent form don’t allow room for interpretation, each phrase has a specific regulatory function, and changing it, even if its purely for stylistic purposes, can invalidate the document when it comes under review by the relevant medical authorities.<\/p>\n

Regulatory risk: what can go wrong in pharmaceutical translation<\/strong><\/h2>\n

Beyond the obvious linguistic errors, the majority of the issues we see in these projects are to do with the initial documentation, rather than with the language itself. Spotting these mistakes before you begin is what makes the differences between a smooth-running project and one which faces regulatory delays.<\/p>\n